Data as of Mar 14
| +0.071 / +7.33%|
The 1 analysts offering 12-month price forecasts for Enzon Pharmaceuticals Inc have a median target of 16.00, with a high estimate of 16.00 and a low estimate of 16.00. The median estimate represents a +1,438.46% increase from the last price of 1.04.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.